Advancing Perinatal Mental Health Care Through the Lens of New Pharmacological Treatments and Clinical Distinction
The landscape of maternal healthcare in the United States underwent a significant shift in March 2019 when the U.S. Food and Drug Administration (FDA) approved brexanolone, marketed under the name…
